Panacea Biotec and RDIF to Produce 100 Million Sputnik V vaccine Doses Yearly
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Panacea Biotec, India’s largest vaccine and pharmaceutical manufacturer, have
Read moreThe Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Panacea Biotec, India’s largest vaccine and pharmaceutical manufacturer, have
Read moreContract Development and Manufacturing Organization Celonic and German biopharmaceutical company CureVac have entered into an agreement to manufacture 100 Million
Read moreGSK has made an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support the production of
Read moreAngelini Pharma and Trueblue enter new collaboration to boost digital transformation and growth with AiDEA’s Artificial Intelligence. Trueblue, a leading provider of AI
Read moreAdienne Pharma & Biotech has signed an agreement for the manufacture of Russia’s Sputnik V COVID-19 vaccine. This paves the
Read moreAgilent Technologies Inc., an American analytical instrumentation manufacturing company, announced it has entered into a definitive agreement to acquire Resolution
Read moreAmgen and Five Prime Therapeutics, a clinical-stage biotech corporation focusing on discovering immuno-oncology and personalized cancer treatments, announced on the
Read moreMerck & Co. is set to boosts its autoimmune diseases pipeline through the acquisition of Pandion Therapeutics for circa $1.85
Read moreBoehringer Ingelheim and Enara Bio reported that they have entered into a strategic partnership and licensing agreement to study and
Read moreSanofi is set to acquire Cambridge, UK-headquartered Kymab and thereby add KY1005 to its pipeline, a human monoclonal antibody targeting
Read more